Healthcare -
Biotechnology - NASDAQ - US
$ 6.85
6.2 %
$ 421 M
Market Cap
-3.85
P/E
GLUE - ACCOUNTS PAYABLE
Accounts Payable GLUE - Monte Rosa Therapeutics, Inc.
11.2 M
LAST VALUE
30.40%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR